Isolation of human melanoma stem cells UNIT 3.8 using ALDH as a marker

Current Protocols in Stem Cell Biology

Volumn 1, Issue SUPPL.26, 2013, Pages

  Luo, Yuchun ^a   Nguyen, Nicholas ^a   Fujita, Mayumi ^a,b,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aldehyde dehydrogenase; Cancer stem cell; Melanoma; Patient derived tumor xenograft

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALUMINUM CHLORIDE; ICE; MATRIGEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CELL ISOLATION; CENTRIFUGE; CONTROLLED STUDY; DISEASE MODEL; FLUORESCENCE ACTIVATED CELL SORTING; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA CELL; MELANOMA STEM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 84891702309     PISSN: 19417322     EISSN: 19388969     Source Type: Journal    
DOI: 10.1002/9780470151808.sc0308s26     Document Type: Article

References (21)

1. Alison, M.R., Guppy, N.J., Lim, S.M., and Nicholson, L.J. 2010. Finding cancer stem cells: Are aldehyde dehydrogenases fit for purpose? J. Pathol. 222:335-344.
2. Burger, P.E., Gupta, R., Xiong, X., Ontiveros, C.S., Salm, S.N., Moscatelli, D., and Wilson, E.L. 2009. High aldehyde dehydrogenase activity: A novel functional marker of murine prostate stem/progenitor cells. Stem Cells 27: 2220-2228.
3. Chute, J.P., Muramoto, G.G., Whitesides, J., Colvin, M., Safi, R., Chao, N.J., and McDonnell, D.P. 2006. Inhibition of aldehydedehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 103:11707-11712.
4. Civenni, G., Walter, A., Kobert, N., Mihic-Probst, D., Zipser, M.,Belloni,B., Seifert, B.,Moch, H., Dummer, R., van den Broek, M., and Sommer, L. 2011. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res. 71:3098-3109.
5. Daniel, V.C., Marchionni, L., Hierman, J.S., Rhodes, J.T., Devereux, W.L., Rudin, C.M., Yung, R., Parmigiani, G., Dorsch, M., Peacock, C.D., and Watkins, D.N. 2009. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res. 69:3364-3373.
6. Ginestier, C., Hur, M.H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C.G., Liu, S., Schott, A., Hayes, D., Birnbaum, D., Wicha, M.S., and Dontu, G. 2007. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555-567.
7. Gray-Schopfer, V., Wellbrock, C., and Marais, R. 2007. Melanoma biology and new targeted therapy. Nature 445:851-857.
8. Jordan, C.T., Guzman, M.L., and Noble, M. 2006. Cancer stem cells. N. Engl. J. Med. 355:1253-1261.
9. Kennedy, J.D., Pierce, C.W., and Lake, J.P. 1992. Extrathymic T cellmaturation. Phenotypic analysis of T cell subsets in nude mice as a function of age. J. Immunol. 148:1620-1629.
10. Levi, B.P., Yilmaz, O.H., Duester, G., and Morrison, S.J. 2009. Aldehyde dehydrogenase 1a1 is dispensable for stem cell function in the mouse hematopoietic and nervous systems. Blood 113:1670-1680.
11. Luo, Y., Dallaglio, K., Chen, Y., Robinson, W.A., Robinson, S.E., McCarter, M.D., Wang, J., Gonzalez, R., Thompson, D.C., Norris, D.A., Roop, D.R., Vasiliou, V., and Fujita, M. 2012a. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells 30:2100-2113.
12. Luo, Y., Ellis, L.Z., Dallaglio, K., Takeda, M., Robinson,W.A.,Robinson, S.E., Liu,W., Lewis, K.D., McCarter, M.D., Gonzalez, R., Norris, D.A., Roop, D.R., Spritz, R.A., Ahn, N.G., and Fujita, M. 2012b. Side population cells fromhuman melanoma tumors reveal diverse mechanisms for chemoresistance. J. Invest. Dermatol. 132:2440-2450.
13. Magni, M., Shammah, S., Schiro, R., Mellado, W., Dalla-Favera, R., and Gianni, A.M. 1996. Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood 87:1097-1103.
14. Prasmickaite, L., Engesaeter, B.O., Skrbo, N., Hellenes, T., Kristian, A., Oliver, N.K., Suo, Z., and Maelandsmo, G.M. 2010. Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. PLoS One 5: e10731.
15. Quintana, E., Shackleton, M., Sabel, M.S., Fullen, D.R., Johnson, T.M., and Morrison, S.J. 2008. Efficient tumour formation by single human melanoma cells. Nature 456:593-598.
16. Quintana, E., Shackleton, M., Foster, H.R., Fullen, D.R., Sabel, M.S., Johnson, T.M., and Morrison, S.J. 2010. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18:510-523.
17. Reya, T., Morrison, S.J., Clarke, M.F., and Weissman, I.L. 2001. Stem cells, cancer, and cancer stem cells. Nature 414:105-111.
18. Rubio-Viqueira, B., Jimeno, A., Cusatis, G., Zhang, X., Iacobuzio-Donahue, C., Karikari, C., Shi, C., Danenberg,K., Danenberg, P.V.,Kuramochi, H., Tanaka, K., Singh, S., Salimi-Moosavi, H., Bouraoud, N., Amador, M.L., Altiok, S., Kulesza, P., Yeo, C., Messersmith, W., Eshleman, J., Hruban, R.H., Maitra, A., and Hidalgo, M. 2006. An in vivo platform for translational drug development in pancreatic cancer. Clin. Cancer Res. 12:4652-4661.
19. Santini, R., Vinci, M.C., Pandolfi, S., Penachioni, J.Y., Montagnani, V., Olivito, B., Gattai, R., Pimpinelli, N., Gerlini, G., Borgognoni, L., and Stecca, B. 2012. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells. Stem Cells 30:1808-1818.
20. Sophos, N.A. and Vasiliou, V. 2003. Aldehyde dehydrogenase gene superfamily: The 2002 update. Chem. Biol. Interact. 143-144:5-22.
21. Tentler, J.J., Tan, A.C., Weekes, C.D., Jimeno, A., Leong, S., Pitts, T.M., Arcaroli, J.J., Messersmith, W.A., and Eckhardt, S.G. 2012. Patient-derived tumour xenografts as models for oncology drug development. Nat. Rev. Clin. Oncol. 9:338-350.